These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 6987993

  • 1. The effect of D-thyroxine on lipoprotein lipids and apolipoproteins in primary type IIa hyperlipoproteinemia.
    Schwandt P, Weisweiler P.
    Atherosclerosis; 1980 Mar; 35(3):301-6. PubMed ID: 6987993
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
    Yovos JG, Patel ST, Falko JM, Newman HA, Hill DS.
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
    [Abstract] [Full Text] [Related]

  • 4. Effects of etiroxate on low density and high density lipoproteins in hypercholesterolemic patients.
    Weisweiler P, Schwandt P.
    Atherosclerosis; 1981 Apr; 39(1):45-9. PubMed ID: 7247989
    [Abstract] [Full Text] [Related]

  • 5. [Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983 Apr; 33(12):1682-4. PubMed ID: 6686774
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
    Tamai T, Nakai T, Yamada S, Kobayashi T, Hayashi T, Kutsumi Y, Takeda R.
    Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
    [Abstract] [Full Text] [Related]

  • 8. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, Chapman MJ.
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [Abstract] [Full Text] [Related]

  • 9. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983 Aug; 33(5):776-9. PubMed ID: 6683558
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Effect of bezafibrate on serum lipid, lipoprotein and apoprotein levels in patients with hyperlipoproteinemia type II and IV].
    Bednarska-Makaruk M, Kuźmińska A, Chotkowska E, Kurjata P, Polakowska M, Broda G, Rywik S.
    Pol Arch Med Wewn; 1992 Mar; 87(3):149-56. PubMed ID: 1523145
    [Abstract] [Full Text] [Related]

  • 13. Effect of bezafibrate on plasma lipids, lipoproteins, apolipoproteins AI, AII and B and LCAT activity in hyperlipidemic, non-insulin-dependent diabetics.
    Prager R, Schernthaner G, Kostner GM, Mühlhauser I, Zechner R, Dorda W.
    Atherosclerosis; 1982 Jun; 43(2-3):321-7. PubMed ID: 6810904
    [Abstract] [Full Text] [Related]

  • 14. Gemfibrozil therapy in primary type II hyperlipoproteinemia: effects on lipids, lipoproteins and apolipoproteins.
    Lupien PJ, Brun D, Gagné C, Moorjani S, Bielman P, Julien P.
    Can J Cardiol; 1991 Jun; 7(1):27-33. PubMed ID: 2025787
    [Abstract] [Full Text] [Related]

  • 15. Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins, and lipoprotein particles.
    Brousseau T, Clavey V, Bard JM, Fruchart JC.
    Clin Chem; 1993 Jun; 39(6):960-4. PubMed ID: 8504564
    [Abstract] [Full Text] [Related]

  • 16. Influence of lovastatin on concentrations and composition of lipoprotein subfractions.
    Nozaki S, Vega GL, Haddox RJ, Dolan ET, Grundy SM.
    Atherosclerosis; 1990 Oct; 84(2-3):101-10. PubMed ID: 2282090
    [Abstract] [Full Text] [Related]

  • 17. Serum lipoprotein composition in different types of hyperlipoproteinemia.
    Carlson LA.
    Adv Exp Med Biol; 1975 Oct; 63():185-99. PubMed ID: 173148
    [Abstract] [Full Text] [Related]

  • 18. [Quantitative analysis of lipoproteins in hyperlipoproteinemias of type IIa, IIb and IV (author's transl)].
    Loeper J, Goy-Loeper J, Rouffy J.
    Clin Chim Acta; 1979 Oct 15; 98(1-2):19-26. PubMed ID: 227624
    [Abstract] [Full Text] [Related]

  • 19. Influence of polyunsaturated fats and fat restriction on serum lipoproteins in humans.
    Weisweiler P, Janetschek P, Schwandt P.
    Metabolism; 1985 Jan 15; 34(1):83-7. PubMed ID: 3965863
    [Abstract] [Full Text] [Related]

  • 20. Effects of nicotinic acid therapy on high-density lipoprotein metabolism in type II and type IV hyperlipoproteinaemia.
    Packard CJ, Stewart JM, Third JL, Morgan HG, Lawrie TD, Shepherd J.
    Biochim Biophys Acta; 1980 Apr 18; 618(1):53-62. PubMed ID: 6990991
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.